RK
Rahul Kumar
About Rahul Kumar
Data last updated:
Rahul Kumar is a Director at Emuric Pharmaceuticals Private Limited (since 2020) and Director at Empiric Pharmaceuticals Private Limited (since 2022). The companies operate in Healthcare and Trading. The largest current company by reported revenue is Emuric Pharmaceuticals Private Limited at ₹18.9 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Emuric Pharmaceuticals Private Limited U85190BR2016PTC031778 | Director | 22 Aug 2020 | 2016 | ₹18.9 Lakh (FY 2025) | Active |
| Empiric Pharmaceuticals Private Limited U51909HP2022PTC009734 | Director | 21 Dec 2022 | 2022 | Active |
Board colleagues of Rahul Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Avinash Kumar | 07534159 | Emuric Pharmaceuticals Private Limited | Director |
| Ravi Ranjan Singh | 07542242 | Emuric Pharmaceuticals Private Limited | Director |
| Priyanka | 09832692 | Empiric Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rahul Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rahul Kumar
Rahul Kumar currently holds 2 directorships: Emuric Pharmaceuticals Private Limited (Director, since 22 Aug 2020, revenue ₹18.9 Lakh (FY 2025)); Empiric Pharmaceuticals Private Limited (Director, since 21 Dec 2022).
Rahul Kumar was first appointed on 22 Aug 2020 as Director at Emuric Pharmaceuticals Private Limited. The most recent appointment on record is 21 Dec 2022 at Empiric Pharmaceuticals Private Limited.
The current boards of Rahul Kumar's companies include Avinash Kumar (Emuric Pharmaceuticals Private Limited), Ravi Ranjan Singh (Emuric Pharmaceuticals Private Limited), Priyanka (Empiric Pharmaceuticals Private Limited).